rs72556258
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_000531.6(OTC):c.409G>A(p.Ala137Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000642 in 1,090,438 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.409G>A | p.Ala137Thr | missense_variant | Exon 5 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.409G>A | p.Ala137Thr | missense_variant | Exon 7 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.409G>A | p.Ala137Thr | missense_variant | Exon 5 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182615Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67251
GnomAD4 exome AF: 0.00000642 AC: 7AN: 1090438Hom.: 0 Cov.: 28 AF XY: 0.0000112 AC XY: 4AN XY: 356184
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
- -
not specified Uncertain:1
Variant summary: OTC c.409G>A (p.Ala137Thr) results in a non-conservative amino acid change located in the aspartate/ornithine carbamoyltransferase, carbamoyl-P binding domain (IPR006132) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 182615 control chromosomes. c.409G>A has been reported in the literature in the heterozygous state in a female and in the hemizygous state in a male whose clinical presentations were not described (Yamaguchi_2006, Sharre_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Ornithine Transcarbamylase Deficiency. At least one in vitro study in COS-7 cells suggests that this variant results in residual enzyme activity of approximately 50% of wildtype and a yeast-based quantitative growth assay suggests that this variant is hypomorhpic and causes a deleterious clinical presentation (e.g. Sharre_2022, Lo_2023). The following publications have been ascertained in the context of this evaluation (PMID: 37146589, 36217298, 16786505). ClinVar contains an entry for this variant (Variation ID: 97193). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Inborn genetic diseases Uncertain:1
The c.409G>A (p.A137T) alteration is located in exon 5 (coding exon 5) of the OTC gene. This alteration results from a G to A substitution at nucleotide position 409, causing the alanine (A) at amino acid position 137 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at